<p>REiNS International Collaboration Members 2016</p><p>Shivani Ahlawat, MD (Johns Hopkins Medical Institute, Whole-Body MRI Working Group); Srivandana Akshintala, MBBS, MPH (National Institutes of Health, Functional Outcomes Working Group); Jeffrey Allen, MD (NYU Langone Medical Center, Member, Visual Outcomes Working Group); Simone Ardern-Holmes, MD (The Children’s Hospital at Westmead, Member, Tumor Measurement, Functional Outcomes, Visual Outcomes and Whole-Body MRI Working Groups); Robert Avery, DO (Children’s National Medical Center, Visual Outcomes Working Group); Amedeo Azizi, MD (Medical University of Vienna); Dusica Babovic-Vuksanovic, MD (Mayo Clinic, Member, Tumor Measurement and Functional Outcomes Working Groups); Annette Bakker, PhD (Children’s Tumor Foundation, President); Andrea Baldwin, CRNP (National Cancer Institute, Member, Patient-Reported Outcomes Working Group); Fred Barker, MD (Massachusetts General Hospital, Member, Tumor Measurement and Functional Outcomes Working Groups); Amanda Bergner, MS CGC (Johns Hopkins Comprehensive Neurofibromatosis Center, Member, Patient-Reported Outcomes Working Group); Chetan Bettegowda, MD, PhD (Johns Hopkins Medical Institute, Biomarkers Working Group); Sucharita Bhaumik, MD (Children’s National Medical Center); Larissa Bilaniuk, MD (The Children’s Hospital of Philadelphia, Member, Visual Outcomes Working Group); Kim Bischoff (Neurofibromatosis, Inc., Executive Director); Jaishri Blakely, MD (John Hopkins Medical Institute, Chair, Whole Body MRI Working Group; Member, Functional Outcomes and Biomarkers Working Groups); Diana Bradford (National Cancer Institute, Tumor Measurement Working Group); Miriam Bredella, MD (Massachusetts General Hospital, Member, Whole-Body MRI Working Group); Wenli Cai, PhD (Massachusetts General Hospital, Whole-Body MRI Working Group); John Carino, MD, MPH (Johns Hopkins Medical Institute, Member, Whole- Body MRI Working Group); Avneesh Chabra, MD (Johns Hopkins Medical Institute, Member, Whole-Body MRI Working Group); Patricia Ciavarelli (University of Buenos Aires); Wade Clapp, MD (Indiana University); Stephen Connor, MD (King’s College Hospital, Member, Tumor Measurement Working Group); Albert Cornelius, MD (Helen DeVos Children’s Hospital); Tambra Dahlheimer, MS, RN (Univeristy of Minnesota); Stephanie Davis, MD (Indiana University); Peter de Blank, MD (UH Rainbow Babies and Children's Hospital, Neurocognitive Working Group); Vidya Dhote (Children’s Tumor Foundation); Joni Doherty, PhD (House Research Institute, Functional Outcomes Working Group); Eva Dombi, MD (National Cancer Institute, Co-Chair, Tumor Measurement Working Group; Member, Whole-Body MRI Working Group); William Dudley, PhD (University of North Carolina Greensboro, Patient Reported Outcomes Working Group); Rachel Ershler, MD (National Institutes of Health; Tumor Measurement and Functional Outcomes Working Group); D. Gareth Evans, MD (St. Mary's Hospital, Member, Tumor Measurement, Whole-Body MRI and Functional Outcomes Working Groups); Laura Fayad, MD (Johns Hopkins Medical Institute, Member, Whole-Body MRI Working Group); Cristina Fernandez-Valle, PhD (University of Central Florida); Rosalie Ferner, MD (Guy's and St. Thomas Hospital, Member, Tumor Meaurement, Patient-Reported Outcomes, and Functional Outcomes Working Groups); Michael Fisher, MD (The Children’s Hospital of Philadelphia, Chair, Visual Outcomes Working Group; Member, Tumor Measurement Working Group); Barbara Franklin (Advocure NF2, Inc., Member, Patient-Reported Outcomes Working Group); Giulia Fulci, PhD (Massachusetts General Hospital); Tracy Galloway (Children’s Tumor Foundation); Kathy Gardner, MD (University of Pittsburgh, Member, Funtional Outcomes and Patient-Reported Outcomes Working Groups); Richard Gedrich (Kolltan Pharmaceuticals); Marco Giovannini, MD, PhD (University of CA Los Angeles) Amy Goldstein, MD (University of Pittsburgh); Anne Goodwin (National Cancer Institutes); Stephane Goutagny, MD, PhD (Hôpital Beaujon, Member, Tumor Measurement Working Group); David Gutmann, MD, PhD (Washington University School of Medicine, Member, Visual Outcomes Working Group); Theresa Hadlock, MD (Massachusetts Eye and Ear Infirmary Member, Functional Outcomes Working Group); Chris Halpin, PhD (Massachusetts Eye and Ear Infirmary, Member, Functional Outcomes Working Group); C. Oliver Hanemann, MD, PhD (Plymouth University Peninsula Schools of Medicine and Dentistry, Chair, Biomarkers Working Group); Kristina Hardy, PhD (Children’s National Medical Center, Member, Neurocognitive Outcomes Working Group); Gordon Harris, PhD (Massachusetts General Hospital, Member, Tumor Measurement and Whole-Body MRI Working Groups); Desiree Headley (Astra Zeneca); Gena Heidary, MD, PhD (Chidlren's Hospital Boston, Vision Outcomes Working Group); Jonathan Heller (Pfizer); Cynthia Hingtgen, MD, PhD (Michigan State University, Member, Patient-Reported Outcomes Working Group); Trent Hummel, MD (Cincinnati Children's Hospital, Functional Outcomes and Vision Outcomes Working Groups); Susan Huson, MD (Central Manchester University Hospitals NHS Trust, Member, Whole-Body MRI Working Group); Michael Jacobs, PhD (Johns Hopkins Medical Institute, Member, Whole-Body MRI Working Group); Jennifer Janusz, PsyD (University of Colorado School of Medicine, Neurocognitive Outcomes Working Group); Diego Jaramillo, MD (The Children’s Hospital of Philadelphia, Member, Tumor Measurement Working Group); Justin Jordan, MD (Massachusetts General Hospital); Allen Julian, MD (Children’s Hospital of Philadelphia, Functional Outcomes Working Group); Michel Kalamarides, MD (Hopital Beaujon, Tumor Measurement Working Group); Matthias Karajannis, MD (NYU Langone Medical Center, Member, Tumor Measurement and Biomarker Working Groups); Bonnie Klein-Tasman, PhD (University of Wisconsin-Milwaukee, Member, Neurocognitive Outcomes Working Group); Pamela Knight (Children’s Tumor Foundation); Bruce Korf, MD, PhD (University of Alabama at Birmingham, Member, Tumor Measurement Working Group); Shannon Langmead, NP (Johns Hopkins Medical Institute); Theresa LaVallee (Kolltan Pharmaceuticals); Fawn Leigh, MD (Massachusetts General Hospital); Donita Lightner, MD (University of Kentucky); Carol Lin, MD (Children's Hospital of Orange County); Robert Listernick, MD (Ann & Robert H. Lurie Children’s Hospital of Chicago, Member, Visual Outcomes Working Group); Grant Liu, MD (The Children’s Hospital of Philadelphia, Member, Visual Outcomes Working Group); Mevo Marco (Children's Tumor Foundation); Carole Marcus, MD (Children’s Hospital of Philadelphia); Gabriella Mariani (Astra Zeneca); Staci Martin, PhD (National Cancer Institute, Member, Patient-Reported Outcomes, Visual Outcomes and Neurocognitive Outcomes Working Groups); Victor Mautner, MD (University Medical Center Hamburg-Eppendorf, Member, Tumor Measurement and Whole-Body MRI Working Groups); Vanessa Merker, BS (Massachusetts General Hospital, Member, Patient-Reported Outcomes Working Group); Michael Ferguson, MD (Indiana University, Biomarkers Working Group); Chris Moertel, MD (University of Minnesota, Functional Outcomes Working Group); Jill Morris, PhD (National Institutes of Health); Katrina Morris, MD (Oxford University Hospitals); Kathryn North, MD (Royal Children’s Hospital, Member, Neurocognitive Outcomes Working Group); Fabio Nunes, MD (Eli Lilly and Company, Member, Biomarkers Working Group); Roger Packer, MD (Children's Medical Center); Laura Papi, MD, PhD (University of Florence); Allyson Parry, MD (Oxford University Hospitals); Neha Patel, MD (University of Wisconsin, Vision Outcomes Working Group); Jonathan Payne, PsyD (The Children’s Hospital at Westmead Member, Neurocognitive Outcomes Working Group); Karen Peluso (Neurofibromatosis, Inc.); Sebastian Perreault, MD (University of Montreal); Scott Plotkin, MD, PhD (Massachusetts General Hospital, Co-Chair, REiNS International Collaboratio; Chair, Functional Outcomes Working Group; Member, Tumor Measurement Working Group); Tina Poussaint, MD (Boston Children's Hospital, Member, Tumor Measurement Working Group); Nancy Ratner, PhD (Cincinnati Children's Hospital); Karlyne Reilly, PhD (National Institutes of Health); Vincent Riccardi, MD (NF Institute); Kent Robertson, MD, PhD (Riley Hospital for Children, Member, Functional Outcomes, Biomarkers and Tumor Measurement Working Groups); Claas Rohl (NF Kinder); Deborah Rukin Gold, MD (University Hospital of Cleveland); La Rosa Salvatore (Children’s Tumor Foundation); Laura Schaffner Gray, PhD (National Cancer Institute, Member, Neurocognitive Outcomes Working Group); Elizabeth Schorry, MD (Cincinnati Children's Hospital Medical Center, Functional Outcomes and Patient-Reported Outcomes Working Groups); Claire Semerjian, MA (Children’s National Medical Center, Neurocognitive Outcomes Working Group); Monica Sheridan, BA (Massachusetts General Hospital); Chie-Schin Shih, MD (Riley Hospital for Children, Member, Tumor Measurement Working Group); Carolyn Sidor (Kolltan Pharmaceuticals); William Slattery III, MD (House Clinic, Member, Functional Outcomes Working Group); Miriam Smith, PhD (St. Mary’s Hospital); Kathy Sommer, RN (University of Minnesota, Neurocognitive Outcomes Working Group); Marigo Stathis (Johns Hopkins Medical Institute); Matt Steensma, MD (Van Andel Institute); Anat Stemmer-Rachamimov, MD (Massachusetts General Hospital, Member, Biomarkers Working Group); David Stevenson, MD (University of Utah); Kari Struemph, PhD (National Institutes of Health); Lara Sullivan (Pfizer); Mary Anne Tamula, MA (NIH Clinical Monitoring Research Program, Member, Neurocognitive Outcomes Workin Group); Mary Thomas (Guy's Hospital); Heather Thompson, PhD, CCC-SLP (California State University, Patient Reported Outcomes Working Group); James Tonsgard, MD (University of Chicago, Member, Functional Outcomes and Patient-Reported Outcomes Working Groups); Nicole Ullrich, MD, PhD (Boston Children’s Hospital, Member, Visual Outcomes and Neurocognitive Working Groups); Sharad Verma, PhD (Johns Hopkins University); David Viskochil, MD, PhD (University of Utah, Functional Outcomes Working Group); Ana-Maria Vranceanu, PhD (Massachusetts General Hospital, Patient Reported Outcomes Working Group); Ute Wahllander (LMU Munich, Functional Outcomes Working Group); Karin Walsh, PsyD (Children’s National Medical Center, Chair, Neurocognitive Outcomes Working Group); Bradley Welling, MD PhD (Ohio State University, Member, Functional Outcomes Working Group); Ralph Wenzel, MD (University Medical Center Hamburg- Eppendorf, Member, Whole-Body MRI Working Group); Trish Whitcomb, RN (National Institutes of Health); Brigitte Widemann, MD (National Cancer Institute, Co-Chair, REiNS Internation Collaboration; Co-chair, Tumor Measurement Working Group; Member, Whole-Body MRI Working Group); Victoria Williams, MD (Guy's Hospital); David Wolf, MD, PhD (Emory University, Functional Outcomes Working Group); Pamela Wolters, PhD (National Cancer Institute, Chair, Patient-Reported Outcomes Working Group; Member, Neurocognitive Outcomes Working Group); Kaleb Yohay, MD (NYU Langone Medical Center, Biomarkers Working Group).</p>